High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda

被引:175
作者
Sampietro, M
Piperno, A
Lupica, L
Arosio, C
Vergani, A
Corbetta, N
Malosio, I
Mattioli, M
Fracanzani, AL
Cappellini, MD
Fiorelli, G
Fargion, S
机构
[1] Univ Milan, Ist Med Interna & Fisiopatol Med, Milan, Italy
[2] Osped Maggiore, IRCCS, I-20122 Milan, Italy
[3] Osped S Gerardo, Div Med 1, Cattedra Med Interna, Monza, Italy
关键词
D O I
10.1002/hep.510270128
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sporadic porphyria cutanea tarda (PCT) is caused by a reduced activity of uroporphyrinogen decarboxylase (URO-D) in the liver, Mild to moderate iron overload is common in PCT, as iron is one of the factors which trigger the clinical manifestations of the disease through the inactivation of URO-D, A role for genetic hemochromatosis in the development of iron overload in sporadic PCT has been hypothesized in the past, The aim of this work was to investigate whether mutations of HFE, which is a candidate gene for hemochromatosis, play the role of genetic susceptibility factors for PCT in Italian patients, who have a high prevalence of acquired triggering factors, such as hepatitis C virus (HCV) chronic infection and alcohol. We determined HFE genotypes of 68 male patients with PCT Our data do not confirm an association of PCT with the Cys282Tyr HFE mutation, strongly associated with hemochromatosis in Northern European countries. A second mutation of HFE, His63Asp, however, had a significantly increased frequency as it was present in half of the patients, Surprisingly, the presence of the His63Asp mutation was not related to the iron status of patients, suggesting that a subtle abnormality of iron metabolism induced by this mutation could escape detection by the standard parameters of iron status, in PCT patients with liver disease, the presence of the mutation could contribute to the inactivation of URO-D, either directly or through a synergistic action with other factors that cause liver damage.
引用
收藏
页码:181 / 184
页数:4
相关论文
共 33 条
[1]   PORPHYRIA-CUTANEA-TARDA AND HLA-LINKED HEMOCHROMATOSIS - ALL IN THE FAMILY [J].
ADAMS, PC ;
POWELL, LW .
GASTROENTEROLOGY, 1987, 92 (06) :2033-2035
[2]  
BARRY M, 1971, LANCET, V1, P100
[3]   Genetic irony beyond haemochromatosis: Clinical effects of HLA-H mutations [J].
Beutler, E .
LANCET, 1997, 349 (9048) :296-297
[4]  
Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027
[5]   Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients [J].
Borot, N ;
Roth, MP ;
Malfroy, L ;
Demangel, C ;
Vinel, JP ;
Pascal, JP ;
Coppin, H .
IMMUNOGENETICS, 1997, 45 (05) :320-324
[6]  
Camaschella C, 1996, HUM GENET, V97, P476
[7]  
Carella M, 1997, AM J HUM GENET, V60, P828
[8]  
CRAWFORD DHG, 1995, AM J HUM GENET, V57, P362
[9]  
de Verneuil H, 1978, Hum Genet, V44, P145
[10]   HLA-LINKED HEMOCHROMATOSIS ALLELES IN SPORADIC PORPHYRIA CUTANEA-TARDA [J].
EDWARDS, CQ ;
GRIFFEN, LM ;
GOLDGAR, DE ;
SKOLNICK, MH ;
KUSHNER, JP .
GASTROENTEROLOGY, 1989, 97 (04) :972-981